Affluent Medical SAS (AFME) — Net Asset Quality Index
Affluent Medical SAS (AFME) has a Net Asset Quality Index of 35.3% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €59.84 Million minus total liabilities of €38.73 Million yields net assets of €21.11 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Affluent Medical SAS (AFME) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Affluent Medical SAS Net Asset Quality Index Over Time (2016–2024)
This chart shows how Affluent Medical SAS's Net Asset Quality Index has evolved across 8 annual periods from 2016 to 2024. As of June 2025, the index stands at 35.3%, representing net assets of €21.11 Million against total assets of €59.84 Million EUR. See Affluent Medical SAS short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Affluent Medical SAS (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Affluent Medical SAS from 2016 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see AFME market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 49.7% | €30.27 Million | €60.86 Million | €30.59 Million | ▼ -5.8 pp |
| 2023 | 55.6% | €31.47 Million | €56.62 Million | €25.15 Million | ▼ -0.8 pp |
| 2022 | 56.4% | €33.83 Million | €60.02 Million | €26.19 Million | ▼ -5.8 pp |
| 2021 | 62.2% | €43.53 Million | €70.03 Million | €26.50 Million | ▲ +7.7 pp |
| 2020 | 54.4% | €35.29 Million | €64.83 Million | €29.54 Million | ▲ +7.0 pp |
| 2019 | 47.5% | €30.96 Million | €65.25 Million | €34.29 Million | ▼ -43.6 pp |
| 2017 | 91.1% | €61.39 Million | €67.39 Million | €6.00 Million | ▼ -4.3 pp |
| 2016 | 95.4% | €58.87 Million | €61.72 Million | €2.85 Million | — |